HealthWarehouse Q3 sales fall amid GLP-1 market shifts

HealthWarehouse.com

12/11/2025 21:41

Overview

HealthWarehouse.com Q3 sales decline 7% due to slowing DTC sales and GLP-1 market shifts

Company reports Q3 net loss of $72,000 but positive cash flow achieved

Year-to-date sales increase 97% over prior year, reflecting strong growth

Outlook

HealthWarehouse.com optimistic about new product launches diversifying its catalog

Company focusing on direct-to-patient market opportunities

HealthWarehouse.com investing in technology for efficiency and scalability

Result Drivers

GLP-1 MARKET SHIFT - Decline in sales driven by reduced compounded GLP-1 prescription sales

DTC SALES DECLINE - Direct-to-consumer prescription sales fell, impacting overall revenue

CASH FLOW POSITIVE - Despite sales decline, company achieved positive cash flow and increased cash reserves

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
$8.4 mln


Press Release: ID:nBwbJfykfa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)